PMC:7408073 / 14242-14410
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"504","span":{"begin":2,"end":6},"obj":"Gene"},{"id":"514","span":{"begin":124,"end":127},"obj":"Gene"},{"id":"517","span":{"begin":54,"end":65},"obj":"Disease"}],"attributes":[{"id":"A504","pred":"tao:has_database_id","subj":"504","obj":"Gene:185"},{"id":"A514","pred":"tao:has_database_id","subj":"514","obj":"Gene:186"},{"id":"A517","pred":"tao:has_database_id","subj":"517","obj":"MESH:D007022"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" (AT1R) pathway, are known to mediate vasodilatative (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving "}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T121","span":{"begin":54,"end":65},"obj":"Disease"}],"attributes":[{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0005468"}],"text":" (AT1R) pathway, are known to mediate vasodilatative (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving "}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T13","span":{"begin":38,"end":52},"obj":"http://purl.obolibrary.org/obo/GO_0042311"}],"text":" (AT1R) pathway, are known to mediate vasodilatative (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving "}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T16","span":{"begin":54,"end":65},"obj":"Phenotype"}],"attributes":[{"id":"A16","pred":"hp_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/HP_0002615"}],"text":" (AT1R) pathway, are known to mediate vasodilatative (hypotension), antiproliferative and apoptotic effects through Mas and AT2 receptors, respectively, both involving "}